Moreover, epibrassinolides increased GSK‐3β phosphorylation and decreased CDK5 expression in tauopathy model PC12 cells, suggesting that epibrassinolides have neuroprotective effects in vitro and in C. elegans model by inhibiting GSK‐3β Ser9 phosphorylation.172. This evidence concerns the gene GSK3B and tauopathy.